Follow
Henrik Keränen
Henrik Keränen
Janssen pharmaceutica
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges
I Kufareva, V Katritch, RC Stevens, R Abagyan
Structure 22 (8), 1120-1139, 2014
1812014
High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C
H Willander, G Askarieh, M Landreh, P Westermark, K Nordling, ...
Proceedings of the National Academy of Sciences 109 (7), 2325-2329, 2012
1432012
Acylguanidine beta secretase 1 inhibitors: A combined experimental and free energy perturbation study
H Keranen, L Pérez-Benito, M Ciordia, F Delgado, TB Steinbrecher, ...
Journal of Chemical Theory and Computation 13 (3), 1439-1453, 2017
712017
Computational identification of uncharacterized cruzain binding sites
JD Durrant, H Keränen, BA Wilson, JA McCammon
PLoS neglected tropical diseases 4 (5), e676, 2010
662010
Structural and Energetic Effects of A2A Adenosine Receptor Mutations on Agonist and Antagonist Binding
H Keränen, H Gutiérrez-de-Terán, J Åqvist
PloS one 9 (10), e108492, 2014
572014
Predicting binding free energies of PDE2 inhibitors. The difficulties of protein conformation
L Pérez-Benito, H Keränen, H van Vlijmen, G Tresadern
Scientific reports 8 (1), 4883, 2018
522018
Novel cruzain inhibitors for the treatment of Chagas’ disease
KE Rogers, H Keränen, JD Durrant, J Ratnam, A Doak, MR Arkin, ...
Chemical biology & drug design 80 (3), 398-405, 2012
452012
Computer simulations of structure–activity relationships for hERG channel blockers
L Boukharta, H Keränen, A Stary-Weinzinger, G Wallin, BL de Groot, ...
Biochemistry 50 (27), 6146-6156, 2011
452011
Free energy calculations of A 2A adenosine receptor mutation effects on agonist binding
H Keränen, J Åqvist, H Gutiérrez-de-Terán
Chemical communications 51 (17), 3522-3525, 2015
442015
X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists
W Jespers, G Verdon, J Azuaje, M Majellaro, H Keränen, X García‐Mera, ...
Angewandte Chemie International Edition 59 (38), 16536-16543, 2020
242020
Computer-aided design of GPCR ligands
H Gutiérrez-de-Terán, H Keränen, J Azuaje, D Rodríguez, J Åqvist, ...
G Protein-Coupled Receptor Screening Assays: Methods and Protocols, 271-291, 2015
142015
PLoS Neglected Trop
JD Durrant, H Keränen, BA Wilson, JA McCammon
Dis 4, e676, 2010
42010
Structural and Energetic Effects of A2A Adenosine Receptor Mutations on Agonist and Antagonist
H Keränen, H Gutiérrez-de-Terán, J Åqvist
2014
Advances in Ligand Binding Predictions using Molecular Dynamics Simulations
H Keränen
Uppsala universitet, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–14